Back to Results
First PageMeta Content
Anatomy / Combination drugs / Enantiopure drugs / Prodrugs / Antihypertensive agents / Heart failure / Enalapril / Novartis / LCZ696 / Pharmacology / Medicine / ACE inhibitors


Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9
Add to Reading List

Document Date: 2014-11-17 07:51:16

Open Document

File Size: 519,27 KB

Share Result on Facebook

City

Toronto / Basel / Dorval / /

Company

Novartis Group / Novartis Pharmaceuticals Canada Inc. / Novartis Novartis Pharmaceuticals Canada Inc. / Novartis AG / Clinical / New England Journal / Regulatory Affairs of Novartis Pharmaceuticals Canada Inc. / Novartis Pharmaceuticals Inc. / /

Country

Switzerland / Germany / Canada / United Kingdom / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

American College of Cardiology / Montreal Heart Institute / Canadian Institute / /

IndustryTerm

protective neurohormonal systems / treatment of heart failure / over-the-counter and animal health products / generic pharmaceuticals / healthcare field / heart failure treatment / diagnostic tools / healthcare solutions / /

MedicalCondition

NYHA Class II-IV heart failure / hospitalized and community-care heart failure / Heart disease / fatigue / investigational heart failure / largest heart failure / Acute heart failure / MEDIA RELEASE Novartis’ investigational heart failure / pancreatic cancer / hypotension / hyperkalemia / congestive heart failure / cancer / disease / chronic heart failure / Canada Heart failure / Heart Failure trial / onset atrial fibrillation / non-serious angioedema / Heart failure / heart failure LCZ696 / chronic systolic heart failure / /

MedicalTreatment

investigational treatment / /

Organization

Montreal Heart Institute / Canadian Cancer Society / European Society of Cardiology / US Securities and Exchange Commission / Canadian Cancer Society’s Advisory Committee on Cancer Statistics / Data Monitoring Committee / the American College / American Heart Association / National Health Service / Canadian Institute for Health Information / /

Person

Jean Godin / Jean-Lucien Rouleau / Patricia Tiramani / /

/

Position

Doughty R.N. / cardiologist / leader / Chief Scientific Officer and Vice-President / member of the PARADIGM-HF executive committee and a co-author / /

Product

LCZ696 / /

ProvinceOrState

Quebec / /

PublishedMedium

Drug Discovery Today / European Heart Journal / the New England Journal of Medicine / /

Technology

pdf / Drug Discovery / /

URL

http /

SocialTag